Investor Highlights

Current:

  • Investor Presentation - view here
  • Quarterly Shareholder Update - view here
  • Investment Summary - view here

Pharmaxis Quarterly Shareholder Update and Investor Presentation

Watch a recording of the Pharmaxis Ltd June Quarterly Shareholder Update by the chief executive officer Mr Gary Phillips on Thursday 29 July 2021.

Watch recording here.

Investor presentation - Quarterly Shareholder Update 29 July 2021

Pharmaxis investor presentation - June 2021 Quarterly Shareholder Update

View presentation – pdf

Shareholder update - June 2021

Shareholder update for the quarter ended 30 June 2021

Read quarterly update - pdf

Emerald Financial Small Caps Watch Interview with CEO Gary Phillips

In an interview with Emerald Financial Small Caps Watch, CEO Gary Phillips explains how the company’s lead drug discovery PXS-5505 is being applied to tackle cancer and the keen interest being shown by scientific and global opinion leaders in the progress of clinical work the company is conducting. Watch the interview here:

Pharmaxis Sells Bronchitol and Aridol Australian Distribution Rights for A$2m

  • Pharmaxis sells Australian distribution rights for Bronchitol®and Aridol® in Australia, New Zealand and several Asian territories to BTC Health effective July 1st, 2021
  • $2m distributor appointment fee to be paid to Pharmaxis
  • Streamlining  mannitol respiratory business in line with strategy
Read full media release - pdf